Aural Analytics Partners with Healint
Aural Analytics and Healint have teamed up to embed speech collection and analytics into Healint's software for clinical trials.
Healint will integrate A2E, Aural Analytics' mobile software development kit and web application programming interface suite, to enable clinical-grade speech and language biomarkers across different human conditions, languages, and ages. The integration will also power multiple patient-facing applications for more than 5 million users across diseases, languages, and operating systems.
Aural Analytics' speech biomarkers platform is designed to support large-scale, late-phase, multilanguage clinical trials and has been adopted in numerous studies by pharmaceutical companies researching neurological and respiratory disease. The integrated offering will support all aspects of Healint's offerings in clinical research, real-world evidence, and market insights.
"We are entering a disruptive era in which clinical trials are brought directly to patients wherever they are, providing nimble recruitment, minimal drop-out, and reliable reporting," said Francois Cadiou, CEO of Healint, in a statement. "Our partnership with Aural Analytics and the integration of their A2E system bolsters the utility of our offering greatly by enabling seamless collection of important neurological, respiratory, and mental health data."
The strategic partnership and integration will also generate large-scale data collection and analysis from millions of active users across Healint's patient-facing applications. The companies intend to explore ways in which patients and users can benefit from a deeper understanding of health, bolstered by clinically validated speech-based outcome measures.
"The combination of our clinical-grade speech biomarker platform and Healint's wide-reaching clinical trial and patient-facing applications will drive data on a scale our industry has not yet seen," said Daniel Jones, CEO and co-founder of Aural Analytics, in a statement. "We are thrilled to partner with Healint to achieve better clinical trial design, setup, and facilitation and to leverage our collective expertise to positively impact the millions of users who rely on Healint to improve their everyday lives."
The U.S. Food and Drug Administration has registered Aural Analytics' speech analytics as a computerized cognitive assessment aid.
Aural Analytics' speech analytics will help assess concussions following in-game injuries.
Medidata's Sensor Cloud Network will include Aural Analytics' Speech Vitals platform.
Aural's Speech Vitals technology will support Koneksa digital biomarker technology during clinical trials of pharmaceuticals.